Spyre Therapeutics, Inc. (SYRE)

NASDAQ: SYRE · IEX Real-Time Price · USD

32.99

-1.26 (-3.68%)

At close: Apr 24, 2024, 4:00 PM

32.36

-0.63 (-1.91%)

After-hours: Apr 24, 2024, 4:06 PM EDT

Spyre Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-338.79	-83.82	-65.8	-80.89	-78.25	-44.35	-27.24	-21.7	-11.52	-10.35
Depreciation & Amortization	0.96	1.96	2	1.62	0.9	0.29	0.25	0.13	0.09	0.02
Share-Based Compensation	25.68	7.11	8.04	6.26	4.88	4.28	2.49	1.22	0.77	0.15
Other Operating Activities	212.24	-5.4	2.05	-2.76	6.79	7.58	-0.12	1.51	-0.54	2.85
Operating Cash Flow	-99.91	-80.14	-53.72	-75.78	-65.69	-32.19	-24.62	-18.84	-10.98	-7.34
Capital Expenditures	0.48	-0.04	-0.57	-4.28	-1.49	-0.42	-0.62	-0.21	-0.21	-0.18
Acquisitions	18.04	0	0	0	0	0	0	0	0	0
Change in Investments	-126.9	57.05	-22.05	-3.32	-0.25	-14.81	-21.91	-11.94	-3.77	0
Other Investing Activities	-	-	-	-	-	-	-	0.08	-0.04	-0.04
Investing Cash Flow	-108.39	57.01	-22.62	-7.6	-1.74	-15.23	-22.53	-12.08	-4.01	-0.22
Share Issuance / Repurchase	84.96	43.1	1.9	154.53	65.75	57.07	12.21	49.37	-2.01	0
Debt Issued / Paid	-0.02	-0.42	-0.51	-0.02	-0.03	0	0	0	0	0
Other Financing Activities	276.13	-	-	-	-	-	-	-	43.68	5.58
Financing Cash Flow	361.08	42.68	1.39	154.51	65.72	57.07	12.21	49.37	41.67	5.58
Exchange Rate Effect	0.03	-0.11	-0.02	0.05	0	0	0	0	0	0
Net Cash Flow	152.8	19.44	-74.96	71.18	-1.71	9.64	-34.93	18.45	26.68	-1.98
Free Cash Flow	-99.44	-80.18	-54.29	-80.06	-67.18	-32.62	-25.23	-19.05	-11.19	-7.52
Free Cash Flow Margin	-11222.91%	-3442.77%	-289.71%	-	-	-838.86%	-484.80%	-411.67%	-183.89%	-
Free Cash Flow Per Share	-14.42	-23.78	-20.64	-37.50	-52.57	-39.16	-41.70	-48.64	-466.42	-1138.79

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).